Protara Therapeutics Inc (NASDAQ:TARA) price on Thursday, July 03, rose 3.96% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.89.
A look at the stock’s price movement, the close in the last trading session was $2.78, moving within a range at $2.8 and $2.92. The beta value (5-Year monthly) was 1.36. Turning to its 52-week performance, $10.48 and $1.60 were the 52-week high and 52-week low respectively. Overall, TARA moved -11.89% over the past month.
Protara Therapeutics Inc’s market cap currently stands at around $111.50 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TARA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend TARA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TARA’s current price about -5.61% and -11.18% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.39, while 7-day volatility ratio is 7.02% and 6.19% in the 30-day chart. Further, Protara Therapeutics Inc (TARA) has a beta value of 1.42. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $12 and high of $12. Looking at the price targets, the low is -315.22% off current price level while to achieve the yearly target high, price needs to move -315.22%. Nonetheless, investors will most likely welcome a -315.22% jump to $12 which is the analysts’ median price.
If we refocus on Protara Therapeutics Inc (NASDAQ:TARA), historical trading data shows that trading volumes averaged 0.76 over the past 10 days and 442.73K over the past 3 months. The company’s latest data on shares outstanding shows there are 38.58 million shares.
The 10.68% of Protara Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 69.41% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.2 million on 2025-06-13, giving us a short ratio of 7.94. The data shows that as of 2025-06-13 short interest in Protara Therapeutics Inc (TARA) stood at 586.0 of shares outstanding, with shares short falling to 2.25 million registered in 2025-05-15. Current price change has pushed the stock 38.28% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TARA stock continues to rise going into the next quarter.
